272 related articles for article (PubMed ID: 8581295)
1. Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia.
Noda Y; Yamada K; Furukawa H; Nabeshima T
Br J Pharmacol; 1995 Nov; 116(5):2531-7. PubMed ID: 8581295
[TBL] [Abstract][Full Text] [Related]
2. [Behavioral assessment of neuroleptics (3)--Schizophrenia negative symptoms-like model induced by PCP].
Noda Y; Nabeshima T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Aug; 16(4):123-8. PubMed ID: 8905801
[TBL] [Abstract][Full Text] [Related]
3. Repeated phencyclidine treatment induces negative symptom-like behavior in forced swimming test in mice: imbalance of prefrontal serotonergic and dopaminergic functions.
Noda Y; Kamei H; Mamiya T; Furukawa H; Nabeshima T
Neuropsychopharmacology; 2000 Oct; 23(4):375-87. PubMed ID: 10989264
[TBL] [Abstract][Full Text] [Related]
4. [Neuropsychopharmacological study on an animal model for negative symptom of schizophrenia induced by repeated phencyclidine treatment].
Noda Y; Nabeshima T
Yakugaku Zasshi; 2000 Aug; 120(8):677-82. PubMed ID: 10946617
[TBL] [Abstract][Full Text] [Related]
5. Effects of antidepressants on phencyclidine-induced enhancement of immobility in a forced swimming test in mice.
Noda Y; Mamiya T; Furukawa H; Nabeshima T
Eur J Pharmacol; 1997 Apr; 324(2-3):135-40. PubMed ID: 9145763
[TBL] [Abstract][Full Text] [Related]
6. Ketamine-enhanced immobility in forced swim test: a possible animal model for the negative symptoms of schizophrenia.
Chindo BA; Adzu B; Yahaya TA; Gamaniel KS
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):310-6. PubMed ID: 22561603
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of immobility induced by repeated phencyclidine injection: association with c-Fos protein in the mouse brain.
Abdel-Naby Sayed M; Noda Y; Mahmoud Hamdy M; Mamiya T; Nagai T; Furukawa H; Nabeshima T
Behav Brain Res; 2001 Sep; 124(1):71-6. PubMed ID: 11423167
[TBL] [Abstract][Full Text] [Related]
8. Risperidone prevents the development of supersensitivity, but not tolerance, to phencyclidine in rats treated with subacute phencyclidine.
Kitaichi K; Yamada K; Yoneda Y; Ogita K; Hasegawa T; Furukawa H; Nabeshima T
Life Sci; 1995; 56(7):531-43. PubMed ID: 7532775
[TBL] [Abstract][Full Text] [Related]
9. Effect of PDE10A inhibitors on MK-801-induced immobility in the forced swim test.
Langen B; Dost R; Egerland U; Stange H; Hoefgen N
Psychopharmacology (Berl); 2012 May; 221(2):249-59. PubMed ID: 22147257
[TBL] [Abstract][Full Text] [Related]
10. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
Nabeshima T; Mouri A; Murai R; Noda Y
Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
[TBL] [Abstract][Full Text] [Related]
11. Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats.
Amitai N; Semenova S; Markou A
Psychopharmacology (Berl); 2007 Sep; 193(4):521-37. PubMed ID: 17497138
[TBL] [Abstract][Full Text] [Related]
12. Clozapine attenuates disruptions in response inhibition and task efficiency induced by repeated phencyclidine administration in the intracranial self-stimulation procedure.
Amitai N; Semenova S; Markou A
Eur J Pharmacol; 2009 Jan; 602(1):78-84. PubMed ID: 19026629
[TBL] [Abstract][Full Text] [Related]
13. Time course of the attenuation effect of repeated antipsychotic treatment on prepulse inhibition disruption induced by repeated phencyclidine treatment.
Li M; He E; Volf N
Pharmacol Biochem Behav; 2011 Jun; 98(4):559-69. PubMed ID: 21402097
[TBL] [Abstract][Full Text] [Related]
14. Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment.
Qiao H; Noda Y; Kamei H; Nagai T; Furukawa H; Miura H; Kayukawa Y; Ohta T; Nabeshima T
Neuroreport; 2001 Jan; 12(1):11-5. PubMed ID: 11201068
[TBL] [Abstract][Full Text] [Related]
15. Subchronic phencyclidine exposure potentiates the behavioral and c-Fos response to stressful stimuli in rats.
Turgeon SM; Lin T; Subramanian M
Pharmacol Biochem Behav; 2007 Nov; 88(1):73-81. PubMed ID: 17698179
[TBL] [Abstract][Full Text] [Related]
16. A test of the predictive validity of animal models of schizophrenia based on phencyclidine and D-amphetamine.
Sams-Dodd F
Neuropsychopharmacology; 1998 Apr; 18(4):293-304. PubMed ID: 9509497
[TBL] [Abstract][Full Text] [Related]
17. Hypofunctional glutamatergic neurotransmission in the prefrontal cortex is involved in the emotional deficit induced by repeated treatment with phencyclidine in mice: implications for abnormalities of glutamate release and NMDA-CaMKII signaling.
Murai R; Noda Y; Matsui K; Kamei H; Mouri A; Matsuba K; Nitta A; Furukawa H; Nabeshima T
Behav Brain Res; 2007 Jun; 180(2):152-60. PubMed ID: 17451820
[TBL] [Abstract][Full Text] [Related]
18. Effect of AD-5423 on animal models of schizophrenia: phencyclidine-induced behavioral changes in mice.
Nagai T; Noda Y; Une T; Furukawa K; Furukawa H; Kan QM; Nabeshima T
Neuroreport; 2003 Feb; 14(2):269-72. PubMed ID: 12598744
[TBL] [Abstract][Full Text] [Related]
19. Atypical antipsychotic effects of quetiapine fumarate in animal models.
Guan HJ; Dai J; Zhu XZ
Acta Pharmacol Sin; 2000 Mar; 21(3):205-10. PubMed ID: 11324416
[TBL] [Abstract][Full Text] [Related]
20. Effects of a glycine transporter-1 inhibitor and D-serine on MK-801-induced immobility in the forced swimming test in rats.
Kawaura K; Koike H; Kinoshita K; Kambe D; Kaku A; Karasawa J; Chaki S; Hikichi H
Behav Brain Res; 2015 Feb; 278():186-92. PubMed ID: 25300471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
